Frontiers in anthelmintic pharmacology

Veterinary Parasitology

Volumn 84, Issue 3-4, 1999, Pages 275-295

  Geary, Timothy G ^a   Sangster, Nicholas C ^b   Thompson, David P ^a  

^a Animal Health Discovery Research   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Anthelmintic; C. elegans; Nematode; Resistance

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; AVERMECTIN; BENZIMIDAZOLE; BENZIMIDAZOLE DERIVATIVE; CLOSANTEL; LEVAMISOLE; MORANTEL; PARAHERQUAMIDE; PYRANTEL; PYRANTEL EMBONATE;

BIOAVAILABILITY; BOVIDS; CATTLE; CONFERENCE PAPER; HELMINTHIASIS; NEMATODE; NEMATODIASIS; NONHUMAN; PARASITE; PARASITE CONTROL; PARASITOLOGY; PHARMACODYNAMICS; SHEEP;

ANIMALS; ANTHELMINTICS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BIOLOGICAL AVAILABILITY; CAENORHABDITIS ELEGANS; CATTLE; CATTLE DISEASES; DEPSIPEPTIDES; DRUG RESISTANCE; HELMINTHIASIS, ANIMAL; HELMINTHS; IVERMECTIN; MACROLIDES; P-GLYCOPROTEINS; PEPTIDES, CYCLIC; PIPERAZINES; SHEEP; SHEEP DISEASES; THIAZOLES;

ANIMALIA; BOS TAURUS; EQUIDAE; OVIS ARIES; VERMES;

EID: 0032991167     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4017(99)00042-4     Document Type: Conference Paper

References (101)

1. Abaza H., El-Zayadi A.R., Kabil S.M., Rizk H. Nitazoxanide in the treatment of patients with intestinal protozoan and helminthic infections: a report on 546 patients in Europe. Curr. Ther. Res. Clin. Exp. 59:1998;116-121.
2. Alvarez, L., Imperiale, F., Sanchez, S., Sallovitz, J., Lanusse, C., 1998. Comparative uptake of albendazole and albendazole sulphoxide by helminth parasites in vivo and in vitro. Proc. American Association of Veterinary Parasitologists Annual Meeting, abstract No. 31.
3. Avery L., Horvitz H.R. Effects of starvation and neuroactive drugs on feeding in Caenorhabditis elegans. J. Exp. Zool. 253:1990;263-270.
4. Bacon J.A., Ulrich R.G., Davis J.P., Thomas E.M., Johnson S.S., Conder G.A., Sangster N.C., Rothwell J.T., McCracken R.O., Lee B.H., Clothier M.F., Geary T.G., Thompson D.P. Comparative in vitro effects of closantel and selected β-ketoamide anthelmintics on a gastrointestinal nematode and vertebrate liver cells. J. Vet. Pharmacol. Therap. 21:1998;190-198.
5. Baggot J.D., McKellar Q.A. The absorption, distribution, distribution and elimination of anthelmintic drugs: the role of pharmacokinetics. J. Vet. Pharmacol. Therap. 17:1994;409-419.
6. Bargmann C.I. Neurobiology of the Caenorhabditis elegans genome. Science. 282:1998;2028-2033.
7. Barnes T.M., Hekimi S. The Caenorhabditis elegans avermectin resistance and anesthetic response gene unc-9 encodes a member of a protein family implicated in electrical coupling of excitable cells. J. Neurochem. 69:1997;2251-2260.
8. Beech R.N., Prichard R.K., Scott M.E. Genetic variability of the beta-tubulin genes in benzimidazole-susceptible and -resistant strains of Haemonchus contortus. Genetics. 138:1994;103-110.
9. Bennett J.L., Pax R.A. Micromotility meter: instrumentation to analyze helminth motility. Parasitol. Today. 3:1987;159-160.
10. Beugnet F., Gauthey M., Kerboeuf D. Partial reversal of benzimidazole resistance by the free-living stages of Haemonchus contortus with verapamil. Vet. Rec. 141:1997;575-576.
11. Bjorn H., Hennessy D.R., Friis C. The kinetic disposition of pyrantel citrate and pamoate and their efficacy against pyrantel-resistant Oesophagostomum dentatum in pigs. Int. J. Parasitol. 26:1996;1375-1380.
12. Blackhall W.J., Pouliot J.-.F., Prichard R.K., Beech R.N. Haemonchus contortus: selection at a glutamate-gated chloride channel gene in ivermectin- and moxidectin-selected strains. Exp. Parasitol. 90:1998;42-48.
13. Blackhall W., Liu H.Y., Xu M., Prichard R.K., Beech R.N. Selection at a P-glcyoprotein gene in ivermectin- and moxidectin-selected strains of Haemonchus contortus. Mol. Biochem. Parasitol. 95:1998;193-201.
14. Blaxter M.L. Caenorhabditis elegans is a nematode. Science. 282:1998;2041-2046.
15. Blaxter, M., Bird, D., 1997. Parasitic nematodes. In: Riddle, D.L., Blumenthal, T., Meyer, B.J., Priess, J.R. (Eds.), C. elegans II. Cold Spring Harbor Laboratory Press, Plainview, NY, pp. 851-878.
16. Blouin M.S., Dame J.B., Tarrant C.A., Courtney C.H. Unusual population genetics of a parasitic nematode: mtDNA variation within and among populations. Evolution. 46:1992;470-476.
17. Blouin M.S., Yowell C.A., Courtney C.H., Dame J.B. Host movement and the genetic structure of populations of parasitic nematodes. Genetics. 141:1995;1007-1014.
18. Boswell M.V., Morgan P.G., Sedensky M.M. Interaction of GABA and volatile anesthetics in the nematode Caenorhabditis elegans. FASEB J. 4:1990;2506-2510.
19. Broeks, A., 1997. P-glycoprotein and multidrug resistance-associated protein function in the nematode Caenorhabditis elegans. Ph.D. Thesis, Vrije Universiteit te Amsterdam, The Netherlands.
20. Broeks A., Janssen H.W.R.M., Calafat J., Plasterk R.H.A. A P-glycoprotein protects Caenorhabditis elegans against natural toxins. EMBO J. 14:1995;1858-1866.
21. Broeks A., Gerrard B., Allikmets R., Dean M., Plasterk R.H.A. Homologues of the human multidrug resistance genes MPR and MDR contribute to heavy metal resistance in the soil nematode Caenorhabditis elegans. EMBO J. 15:1996;6132-6143.
22. Brglin T.R., Lobos E., Blaxter M.L. Caenorhabditis elegans as a model for parasitic nematodes. Int. J. Parasitol. 28:1998;395-411.
23. C. elegans Sequencing Consortium, 1998. Genome sequence of the nematode C. elegans a platform for investigating biology. Science 282, 2012-2018.
24. Cabello R.R., Guerrero L.R., Garcia M.D.M., Cruz A.G. Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico. Trans. Royal Soc. Trop. Med. Hyg. 91:1997;701-703.
25. Chen W., Terada M., Cheng J.T. Characterization of subtypes of gamma-aminobutyric acid receptors in an Ascaris muscle preparation by binding assay and binding of PF1022A, a new anthelmintic, on the receptors. Parasitol. Res. 82:1996;97-101.
26. Chow L.M.C., Volkman S.K. Plasmodium and Leishmania: The role of mdr genes in mediating drug resistance. Exp. Parasitol. 90:1998;135-141.
27. Coles G.C., Stafford K.A., MacKay P.H. Ivermectin-resistant Cooperia species from calves on a farm in Somerset. Vet. Rec. 142:1998;255-256.
28. Conder G.A., Campbell W.C. Chemotherapy of nematode infections of veterinary importance, with special reference to drug resistance. Adv. Parasitol. 35:1995;1-84.
29. Conder G.A., Johnson S.S., Nowakowski D.S., Blake T.E., Dutton F.E., Nelson S.J., Thomas E.M., Davis J.P., Thompson D.P. Anthelmintic profile of the cyclodepsipeptide PF1022A in in vitro and in vivo models. J. Antibiot. 48:1995;820-823.
30. Cully D.F., Wilkinson H., Vassilatis D.K., Etter A., Arena J.P. Molecular biology and electrophysiology of glutamate-gated chloride channels of invertebrates. Parasitology. 113:1996;S191-S200.
31. Dent J.A., Davis M.W., Avery L. avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans. EMBO J. 16:1997;5867-5879.
32. Doumbo O., Rossignol J.F., Pichard E., Traore H.A., Dembele M., Diakite M., Traore F., Diaalo D.A. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in Africa. Am. J. Trop. Med. Hyg. 56:1997;637-639.
33. Driscoll M., Dean E., Reilly E., Bergholz E., Chalfie M. Genetic and molecular analysis of a Caenorhabditis elegans β-tubulin that conveys benzimidazole sensitivity. J. Cell Biol. 109:1989;2993-3003.
34. Elard L., Comes A.M., Humbert J.F. Sequences of β-tubulin cDNA from benzimidazole-susceptible and -resistant strains of Teladorsagia circumcincta, a nematode parasite of small ruminants. Mol. Biochem. Parasitol. 79:1996;249-253.
35. Elard L., Cabaret J., Humbert J.F. PCR diagnosis of benzimidazole-susceptibility or -resistance in natural populations of the small ruminant parasite, Teladorsagia circumcincta. Vet. Parasitol. 80:1999;231-237.
36. Euzeby J., Promtep S., Rossignol J.F. Experimentation des Properties Anthelminthiques de la Nitazoxanide Chex le Chien, le Chat et les Ovins. Rev. Med. Vet. 131:1980;687-696.
37. Fleming J.T., Baylis H.A., Sattelle D.B., Lewis J.A. Molecular cloning and in vitro expression of C. elegans and parasitic nematode ionotropic receptors. Parasitology. 113:1996;S175-S190.
38. Fleming J.T., Squire M.D., Barnes T.M., Tornoe C., Matsuda K., Ahnn J., Fire A., Sulston J.E., Barnard E.A., Satelle D.B., Lewis J.A. Caenorhabditis elegans levamisole resistance genes lev-1, unc-29 and unc-38 encode functional nicotinic acetylcholine receptor subunits. J. Neurosci. 17:1997;5843-5857.
39. Geary T.G., Nulf S.C., Favreau M.A., Tang L., Prichard R.K., Hatzenbuhler N.T., Shea M.H., Alexander S.J., Klein R.D. Three β-tubulin cDNAs from the parasitic nematode Haemonchus contortus. Mol. Biochem. Parasitol. 50:1992;295-306.
40. Geary T.G., Sims S.M., Thomas E.M., Vanover L., Davis J.P., Winterrowd C.A., Klein R.D., Ho N.F.H., Thompson D.P. Haemonchus contortus: ivermectin-induced paralysis of the pharynx. Exp. Parasitol. 77:1993;88-96.
41. Geary, T.G., Blair, K.L., Ho, N.F.H., Sims, S.M., Thompson, D.P., 1995. Biological functions of nematode surfaces. In: Boothroyd, J.C., Komuniecki, R. (Eds.), Molecular Approaches to Parasitology. Wiley-Liss, New York, pp. 57-76.
42. Geary T.G., Thompson D.P., Klein R.D. Mechanism-based screening: discovery of the next generation of anthelmintics depends upon more basic research. Int. J. Parasitol. 29:1999;105-112.
43. Geyner G., Meder S., Rink T., Boheim G., Harder A., Jeschke P., Scherkenbeck J., Londershausen M. Ionophore and anthelmintic activity of PF1022A, a cyclodepsipeptide, are not related. Pestic. Sci. 48:1996;399-407.
44. Gill J.H., Lacey E. In vitro activity of paraherquamide against the free-living stages of Haemonchus contortus, Trichostrongylus colubriformis and Ostertagia circumcincta. Int. J. Parasitol. 23:1993;375-381.
45. Gill J.H., Lacey E. Avermectin/milbemycin resistance in trichostrongylid nematodes. Int. J. Parasitol. 28:1998;863-877.
46. Gill J.H., Kerr C.A., Shoop W.L., Lacey E. Evidence of multiple mechanisms of avermectin resistance in Haemonchus contortus - comparison of selection protocols. Int. J. Parasitol. 28:1998;783-789.
47. Grant W. Genetic variation in parasitic nematodes and its implications. Int. J. Parasitol. 24:1994;821-830.
48. Grant W., Mascord L.J. Beta-tubulin gene polymorphism and benzimidazole resistance in Trichostrongylus colubriformis. Int. J. Parasitol. 26:1996;71-77.
49. Hennessy D.R. Modifying the formulation or delivery mechanism to increase the activity of anthelmintic compounds. Vet. Parasitol. 72:1997;367-390.
50. Ho N.F.H., Sims S.M., Vidmar T.J., Day J.S., Barsuhn C.L., Thomas E.M., Geary T.G., Thompson D.P. Theoretical perspectives on anthelmintic drug discovery: interplay of transport kinetics, physicochemical properties, and in vitro activity of anthelmintic drugs. J. Pharm. Sci. 83:1994;1052-1059.
51. Ibarra O.F., Jenkins D.C. The relevance of in vitro anthelmintic screening tests employing the free-living stages of trichostrongylid nematodes. J. Helminth. 58:1988;107-112.
52. Janke D.L., Schein J.E., Ha T., Franz N.W., O'Neil N.J., Vatcher G.P., Stewart H.I., Kuervers L.M., Baillie D.L., Rose A.M. Interpreting a sequenced genome: toward a cosmid transgenic library of Caenorhabditis elegans. Genome Res. 7:1997;974-985.
53. Jenkins D.C., Rapson E.B., Topley P. The aggregation response of Trichostrongylus colubriformis: a basis for the rapid interpretation of in vitro anthelmintic screens. Parasitology. 93:1986;531-537.
54. Kachi S., Terada M., Hashimoto H. Effects of amorphous and polymorphs of PF1022A, a new antinematode drug, on Angiostrongylus cantonensis in mice. Jpn. J. Pharmacol. 77:1998;235-245.
55. Kwa M.S., Veenstra J.G., Roos M.H. Benzimidazole resistance in Haemonchus contortus is correlated with a conserved mutation at amino acid 200 in β-tubulin isotype 1. Mol. Biochem. Parasitol. 63:1994;299-303.
56. Kwa M.S., Veenstra J.G., Van Dijk M., Roos M.H. β-tubulin genes from the parasitic nematode Haemonchus contortus modulate drug resistance in Caenorhabditis elegans. J. Mol. Biol. 246:1995;500-510.
57. Kwa M.S.G., Okoli M.N., Schulz-Key H., Okongkwo P.O., Roos M.H. Use of P-glycoprotein gene probes to investigate anthelmintic resistance in Haemonchus contortus and comparison with Onchocerca volvulus. Int. J. Parasitol. 28:1998;1235-1240.
58. Lanusse C.E., Prichard R.K. Relationship between pharmacological properties and clinical efficacy of ruminant anthelmintics. Vet. Parasitol. 49:1993;123-158.
59. Lanusse C.E., Virkel G.L., Sanchez S.F., Alvarez L.I., Lifschitz A.L., Imperiale F. Ricobendazole kinetics and availability following subcutaneous administration of a novel injectable formulation to calves. Res. Vet. Sci. 65:1998;5-10.
60. Larsen M., Nansen P., GrMnvold J., Wolstrup J., Henriksen S.A. Biological control of gastro-intestinal nematodes - facts, future, or friction? Vet. Parasitol. 72:1997;479-492.
61. Lewis J.A., Wu C.-.H., Berg H., Levine J.H. The genetics of levamisole resistance in the nematode Caenorhabditis elegans. Genetics. 95:1980;905-928.
62. Lewis J.A., Wu C.-.H., Levine J.H., Berg H. Levamisole-resistant mutants of the nematode Caenorhabditis elegans appear to lack pharmacological acetylcholine receptors. Neuroscience. 5:1980;967-989.
63. Lewis J.A., Elmer J.S., Skimming J., McLafferty S., Fleming J., McGee T. Cholinergic receptor mutants of the nematode Caenorhabditis elegans. J. Neurosci. 7:1987;3059-3071.
64. Lifschitz, A., Virkel, G., Sutra, J., Galtier, P., Alvinerie, M., Lanusse, C., 1998. Distribution of endectocide compounds to target tissues in cattle. Proc. American Association of Veterinary Parasitologists Annual Meeting, abstract 68.
65. Lincke C.R., The I., van Groenigen M., Borst P. The P-glycoprotein gene family of Caenorhabditis elegans. Cloning and characterization of genomic and complementary DNA sequences. J. Mol. Biol. 228:1992;701-711.
66. Lincke C.R., Broeks A., The I., Plasterk R.H.A., Borst P. The expression of two P-glycoprotein (pgp) genes in transgenic Caenorhabditis elegans is confined to intestinal cells. EMBO J. 12:1993;1615-1620.
67. Martin R.J., Harder A., Londershausen M., Jeschke P. Anthelmintic actions of the cyclic depsipeptide PF1022A and its electrophysiological effects on muscle cells of Ascaris suum. Pestic. Sci. 48:1996;343-349.
68. Martin R.J. Modes of action of anthelmintic drugs. Vet. J. 154:1997;11-34.
69. Martin R.J., Robertson A.P., Bjorn H., Sangster N.C. Heterogenous levamisole receptors: a single-channel study of nicotinic acetylcholine receptors from Oesophagostomum dentatum. Eur. J. Pharmacol. 322:1997;249-257.
70. Nadler S. Molecular approaches to studying helminth population genetics and phylogeny. Int. J. Parasitol. 20:1990;11-29.
71. Nare B., Liu Z., Prichard R.K., Georges E. Benzimidazoles, potent anti-mitotic drugs, are substrates for the P-glycoprotein transporter in multidrug resistant cells. Biochem. Pharmacol. 48:1994;2215-2222.
72. Ostlind D.A., Mickle W.G., Ewaniw D.V., Andriuli F.J., Campbell W.C., Hernandez S., Mochales S., Munguira E. Efficacy of paraherquamide against immature Trichostrongylus colubriformis in the gerbil (Meriones unguiculatus). Res. Vet. Sci. 48:1990;260-261.
73. Petersen M.B., Friis C., Bjorn H. A new in vitro assay of benzimidazole activity against adult Oesophagostomum dentatum. Int. J. Parasitol. 27:1997;1333-1339.
74. Pouliot J.F., L'Heureux F., Liu Z., Prichard R.K., Georges E. Reversal of P-glycoprotein-associated multidrug resistance by ivermectin. Biochem. Pharmacol. 53:1997;17-25.
75. Rand J.B., Johnson C.D. Genetic pharmacology: interactions between drugs and gene products in Caenorhabditis elegans. Meth. Cell Biol. 48:1995;187-204.
76. Rapson E.B., Jenkins D.C., Topley P. Trichostrongylus colubriformis: in vitro culture of parasitic stages and their use for the evaluation of anthelmintics. Res. Vet. Sci. 39:1985;90-94.
77. Rapson E.B., Jenkins D.C., Chilwan A.S. Improved detection of anthelmintic activity in an in vitro screen utilizing adult Nippostrongylus brasiliensis. Parasitol. Res. 73:1987;190-191.
78. Roos M.H., Kwa M.S.G., Veenstra J.G., Kooyman F.N.J., Boersema J.H. Molecular aspects of drug resistance in parasitic helminths. Pharmacol. Ther. 60:1993;331-336.
79. Rothwell J.T., Sangster N.C. Haemonchus contortus: the uptake and metabolism of closantel. Int. J. Parasitol. 27:1997;313-319.
80. Sangster N.C. P-glycoproteins in nematodes. Parasitol. Today. 10:1994;319-322.
81. Sangster N.C. Pharmacology of anthelmintic resistance. Parasitology. 113:1996;S201-S216.
82. Sangster N.C., Redwin J.M., Bjorn H. Inheritance of levamisole and benzimidazole resistance in an isolate of Haemonchus contortus. Int. J. Parasitol. 28:1998;503-510.
83. 3 ]m-aminolevamisole to receptors in levamisole-susceptible and -resistant Haemonchus contortus Int. J. Parasitol. 28:1998;707-717.
84. Sangster N.C., Bannan S.C., Weiss A.S., Nulf S.C., Klein R.D., Geary T.G. Haemonchus contortus: sequence heterogeneity of internucleotide binding domains from P-glycoproteins and an association with avermectin/milbemycin resistance. Exp. Parasitol. 91:1999;250-257.
85. Sasaki T., Takagi M., Yaguchi T., Miyadoh S., Okada T., Koyama M. A new anthelmintic cyclodepsipeptide, PF1022A. J. Antibiot. 45:1992;692-697.
86. Savage C., Chalfie M. Genetic aspects of microtubule biology in the nematode Caenorhabditis elegans. Cell Motil. Cytoskel. 18:1991;159-163.
87. Schinkel A.H., Smit J.J.M., Van Tellingen O., Beijnen J.H., Wagenarr E., Van Deemter L., Mol C.A.A.M., Van der Valk M.A., Robanus-Maandag E.C., Te Riele H.P.J., Berns A.J.M., Borst P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 77:1994;491-502.
88. Shoop W.L., Egerton J.R., Eary C.H., Suhayda D. Anthelmintic activity of paraherqaumide in sheep. J. Parasitol. 76:1990;349-351.
89. Shoop W.L., Eary C.H., Michael H.W., Haines H.W., Seward R.L. Anthelmintic activity of paraherquamide in dogs. Vet. Parasitol. 40:1991;339-341.
90. Shoop W.L., Michael B.F., Haines H.W., Eary C.H. Anthelmintic activity of paraherquamide in calves. Vet. Parasitol. 43:1992;259-263.
91. Shoop W.L., Haines H.W., Eary C.H., Michael B.F. Acute toxicity of paraherquamide and its potential as an anthelmintic. Am. J. Vet. Res. 53:1992;2032-2034.
92. Simpkin K.G., Coles G.C. The use of Caenorhabditis elegans for anthelmintic screening. J. Chem. Tech. Biotech. 31:1981;66-69.
93. Sims S.M., Ho N.F.H., Geary T.G., Thomas E.M., Day J.S., Barsuhn C.L., Thompson D.P. Influence of organic acid excretion on cuticle pH and drug absorption by Haemonchus contortus. Int. J. Parasitol. 26:1996;25-35.
94. Starich T.A., Herman R.K., Shaw J.E. Molecular and genetic analysis of unc-7, a Caenorhabditis elegans gene required for coordinated locomotion. Genetics. 133:1993;527-541.
95. Stringfellow F. Cultivation of Haemonchus contortus (Nematoda: Trichostrongylidae) from infective larvae to the adult male and the egg-laying female. J. Parasitol. 72:1986;339-345.
96. Thompson D.P., Klein R.D., Geary T.G. Prospects for rational approaches to anthelmintic discovery. Parasitology. 113:1996;S217-S238.
97. Vassilatis D.K., Arena J.P., Plasterk R.H.A., Wilkinson H.A., Schaeffer J.M., Cully D.F., van der Ploeg L.H.T. Genetic and biochemical evidence for a novel avermectin-sensitive chloride channel in Caenorhabditis elegans - isolation and characterization. J. Biol. Chem. 272:1997;33167-33174.
98. Vermunt J.J., West D.M., Pomroy W.E. Multiple resistance to ivermectin and oxfendazole in Cooperia species of cattle in New Zealand. Vet. Rec. 137:1995;43-45.
99. Vermunt J.J., West D.M., Pomroy W.E. Inefficacy of moxidectin and doramectin against ivermectin-resistant Cooperia spp. of cattle in New Zealand. New Zealand Vet. J. 44:1996;188-193.
100. Waller P.J. Anthelmintic resistance. Vet. Parasitol. 72:1997;391-412.
101. Xu M., Molento M., Blackhall W., Ribeiro P., Beech R., Prichard R. Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog. Mol. Biochem. Parasitol. 91:1998;327-335.